Funding Details
- Awarder
- StartEngine
- Date Award
- April 24, 2024
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Premoney Valuation
-
$40,000,000
- Valuation
-
$40,000,000
Company Info
- Founding Year
- Not provided
- Traction
- None
- Organizations Involved
- None
- Founders
- Dean Hart, Michelle L. Shuffett, Curtis Rhine, Justin Molignoni
- Company Description
- RS BioTherapeutics is developing a groundbreaking drug platform to address inflammatory lung diseases like Chronic Obstructive Pulmonary Disease (COPD) and Idiopathic Pulmonary Fibrosis (IPF). Their science-backed approach offers new treatment avenues not just for these respiratory diseases, but many others that could be addressed using their innovative platform.
- Market
- Respiratory Diseases
- Location
-
Cumberland,
MD,
US
- Coinvestors
- None
Links